Indevus Pharmaceuticals

From WikiCover

Jump to: navigation, search

Indevus Pharmaceuticals is a specialty pharmaceutical company engaged in the acquisition, development and commercialization of products to treat conditions in urology and endocrinology. The Company's approved products include Sanctura for overactive bladder, Vantas for advanced prostate cancer, Delatestrl to treat male hypogonadism, and Supprelin LA, a puberty hormone suppressor for central precocious puberty. The Indevus development pipeline contains multiple compounds within the Company's core therapeutic areas in addition to several partnered or partnerable programs. The most advanced compounds in development include Sanctura XR, the once-daily formulation of Sanctura, Valstar for bladder cancer, Nebido for male hypogonadism, PRO 2000 for the prevention of infection by HIV and other sexually-transmitted pathogens, and pagoclone for stuttering.

Name (required):

Comment:

Headquarters: 33 Hayden Avenue, Lexington, MA 02421

Website: http://www.indevus.com/

Retrieved from "http://www.wikicover.com/Indevus_Pharmaceuticals"